Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Regains Compliance with Nasdaq Rule

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker said in a filing with the US Securities and Exchange Commission today that it has regained compliance with certain Nasdaq regulations.

The firm received a letter from Nasdaq on March 25, informing it that it was not in compliance with the stock market's rule that a firm must have at least three independent directors on its audit committee. The letter came after Bruker announced that Collin D'Silva, an independent director and member of the firm's audit committee, had resigned.

Nasdaq sent another letter to Bruker on April 1, which informed the firm that it also was not in compliance with a rule that the majority of its board must be comprised of independent directors.

The firm regained compliance with both rules after its election last week of Charles Wagner to serve on its board and its audit committee. Wagner most recently served as CFO of Millipore, prior to that firm's acquisition by Merck KGaA.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.